ITGAX and systemic lupus erythematosus: Consistent with these findings, we demonstrate that administration of the A2A receptor agonist CGS-21680 depleted CD11c+T-bet+ B cells generated in both E. muris-infected and lupus-prone mice, and reduced disease burden in autoimmune-prone mice.